Skip to main content

Table 2 Treatment-Related Adverse Events

From: A prospective phase-II trial of biweekly docetaxel plus androgen deprivation therapy in patients with previously-untreated metastatic castration-naïve prostate cancer

Adverse events

All Grades

%

Grade ≥ 3

%

Nail change

14

33.3

0

 

Fatigue

12

28.6

0

 

Mucositis

11

26.2

0

 

Alopecia

9

21.4

0

 

Neuropathy

8

19.0

0

 

Constipation

7

19.0

0

 

Pain

7

16.7

0

 

Insomnia

6

14.3

0

 

Rash

5

11.9

0

 

Anorexia

5

11.9

0

 

Lacrimation

5

11.9

0

 

Dizziness

3

7.1

0

 

Diarrhea

3

7.1

1

2.4

Localized Edema

2

4.8

0

 

Chest discomfort

2

4.8

0

 

Pruritus

2

4.8

0

 

Dyspnea

2

4.8

0

 

Facial flushing

2

4.8

0

 

Pneumonitis

2

4.8

2

4.8

Nocturia

1

2.4

0

 

Myalgia

1

2.4

0

 

Sore throat

1

2.4

0

 

Anemia

40

95.2

0

 

Lymphopenia

13

31

2

4.8

Neutropenia

11

26.2

1

2.4

Thrombocytopenia

8

19

0

 

AST elevation

1

2.4

0

 

ALT elevation

1

2.4

0

 
  1. AST aspartate aminotransferase, ALT alanine aminotransferase